X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3108) 3108
Publication (111) 111
Book Review (42) 42
Magazine Article (12) 12
Book Chapter (9) 9
Book / eBook (6) 6
Conference Proceeding (1) 1
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2611) 2611
pyridoxine - therapeutic use (2257) 2257
female (1488) 1488
male (1356) 1356
adult (884) 884
middle aged (629) 629
pyridoxine (522) 522
animals (462) 462
child (413) 413
aged (391) 391
adolescent (341) 341
index medicus (340) 340
pyridoxine - administration & dosage (308) 308
pregnancy (265) 265
child, preschool (257) 257
infant (251) 251
vitamin b 12 - therapeutic use (226) 226
rats (215) 215
folic acid - therapeutic use (208) 208
pyridoxine - pharmacology (186) 186
infant, newborn (184) 184
pediatrics (179) 179
drug therapy, combination (171) 171
pharmacology & pharmacy (165) 165
thiamine - therapeutic use (163) 163
time factors (163) 163
vitamin b complex - therapeutic use (162) 162
pyridoxine - metabolism (161) 161
treatment outcome (157) 157
drug combinations (156) 156
isoniazid - therapeutic use (152) 152
clinical neurology (144) 144
medicine, general & internal (143) 143
vitamin b6 (142) 142
epilepsy (133) 133
homocysteine - blood (126) 126
seizures (126) 126
seizures - drug therapy (124) 124
homocystinuria - drug therapy (122) 122
clinical trials as topic (116) 116
vitamin b 6 deficiency - drug therapy (116) 116
double-blind method (113) 113
pyridoxine - adverse effects (113) 113
electroencephalography (112) 112
ascorbic acid - therapeutic use (104) 104
epilepsy - drug therapy (99) 99
tryptophan - metabolism (99) 99
risk factors (98) 98
vitamins - therapeutic use (95) 95
homocysteine (94) 94
anticonvulsants - therapeutic use (92) 92
diet (91) 91
health aspects (89) 89
dose-response relationship, drug (88) 88
mice (88) 88
pyridoxine - blood (87) 87
anemia, sideroblastic - drug therapy (86) 86
metabolism (86) 86
vitamins (85) 85
follow-up studies (84) 84
vitamin b 6 deficiency - complications (79) 79
therapy (77) 77
folic acid (76) 76
vitamin b (76) 76
mutation (74) 74
tuberculosis, pulmonary - drug therapy (74) 74
administration, oral (72) 72
dietary supplements (72) 72
isoniazid - adverse effects (72) 72
pyridoxal phosphate - blood (72) 72
vitamin b 6 - therapeutic use (72) 72
nutrition & dietetics (71) 71
neurosciences (70) 70
isoniazid - poisoning (67) 67
aspartate aminotransferases - blood (66) 66
diagnosis (66) 66
diagnosis, differential (65) 65
care and treatment (64) 64
riboflavin - therapeutic use (63) 63
analysis (62) 62
research article (61) 61
antiemetics - therapeutic use (60) 60
medicine & public health (59) 59
placebos (58) 58
parkinson disease - drug therapy (57) 57
diet therapy (56) 56
double-blind (56) 56
pyridoxine - analogs & derivatives (56) 56
renal dialysis (56) 56
xanthurenates - urine (56) 56
endocrinology & metabolism (55) 55
erythrocytes - enzymology (55) 55
physiological aspects (55) 55
deficiency (54) 54
seizures - etiology (54) 54
pregnancy complications - drug therapy (53) 53
seizures - chemically induced (52) 52
urology & nephrology (52) 52
vitamin b 6 deficiency - metabolism (52) 52
children (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2328) 2328
German (195) 195
Russian (178) 178
French (140) 140
Italian (119) 119
Spanish (43) 43
Japanese (37) 37
Polish (19) 19
Dutch (10) 10
Norwegian (9) 9
Chinese (7) 7
Romanian (7) 7
Czech (6) 6
Danish (6) 6
Hungarian (6) 6
Portuguese (5) 5
Hebrew (3) 3
Slovak (3) 3
Swedish (3) 3
Bulgarian (2) 2
Serbian (2) 2
Croatian (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychiatry and Clinical Neurosciences, ISSN 1323-1316, 06/2015, Volume 69, Issue 6, pp. 321 - 334
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking... 
first‐generation agents | schizophrenia | management | second‐generation agents | tardive dyskinesia | second-generation agents | first-generation agents | VITAMIN-E TREATMENT | NEUROTROPHIC FACTOR LEVELS | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | GINKGO-BILOBA | CHAIN AMINO-ACIDS | NEUROSCIENCES | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | HYPERKINETIC MOVEMENT-DISORDERS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | ESSENTIAL FATTY-ACIDS | Stilbenes - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Propranolol - therapeutic use | Leucine - therapeutic use | Dopamine Agents - therapeutic use | Amantadine - therapeutic use | Piracetam - therapeutic use | Pyridoxine - therapeutic use | Clonazepam - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Adrenergic Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Isoleucine - therapeutic use | Vitamins - therapeutic use | Ginkgo biloba | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Movement Disorders - etiology | Piracetam - analogs & derivatives | Melatonin - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Valine - therapeutic use | Isoxazoles - therapeutic use | Plant Extracts - therapeutic use | Movement Disorders - drug therapy | Tetrabenazine - therapeutic use | Schizophrenia | Movement disorders | Tardive dyskinesia | Medical research
Journal Article
Expert Review of Neurotherapeutics, ISSN 1473-7175, 02/2016, Volume 16, Issue 2, pp. 131 - 144
Adult Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition associated with high disability and frequent comorbidity. Current... 
Antidepressants | Attention Deficit Hyperactivity Disorder (ADHD) | Amphetamines | Efficacy | Lithium | Adults | Pharmacological Treatment | Metadoxine | ALZHEIMERS-DISEASE | BUPROPION TREATMENT | DEFICIT-HYPERACTIVITY DISORDER | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | MIXED AMPHETAMINE SALTS | RESPONSE-INHIBITION | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | LISDEXAMFETAMINE DIMESYLATE | RECEPTOR AGONIST | METADOXINE EXTENDED-RELEASE | Humans | Paroxetine - therapeutic use | Venlafaxine Hydrochloride - therapeutic use | Dopamine Agents - therapeutic use | Droxidopa - therapeutic use | Pyrrolidonecarboxylic Acid - therapeutic use | Adrenergic alpha-Agonists - therapeutic use | Histamine Agents - therapeutic use | Central Nervous System Stimulants - therapeutic use | Desipramine - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Pyridoxine - therapeutic use | Adult | Lobeline - therapeutic use | Benzhydryl Compounds - therapeutic use | Nomifensine - therapeutic use | Morpholines - therapeutic use | Bupropion - therapeutic use | Pyridines - therapeutic use | Wakefulness-Promoting Agents - therapeutic use | Duloxetine Hydrochloride - therapeutic use | Guanfacine - therapeutic use | Nicotinic Agonists - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Mecamylamine - therapeutic use | Amphetamines - therapeutic use | Lithium Compounds - therapeutic use | Lisdexamfetamine Dimesylate - therapeutic use | Nicotinic Antagonists - therapeutic use | Quinazolinones - therapeutic use | Memantine - therapeutic use | Drug Combinations
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 04/2017, Volume 45, Issue 7, pp. 865 - 882
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 3, pp. 233 - 245
Journal Article